Skip to content
healthcare.dev

Atovaquone

NDC 42239-001, Atovaquone, suspension, from Abon Pharmaceuticals, LLC.

Product NDC
42239-001
Status
Listed
Labeler
Abon Pharmaceuticals, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214272
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42239-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
42239-001-08422390001081 BOTTLE in 1 CARTON (42239-001-08) / 210 mL in 1 BOTTLE
42239-001-66422390001666 CUP, UNIT-DOSE in 1 TRAY (42239-001-66) / 5 mL in 1 CUP, UNIT-DOSE (42239-001-17)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08

Use it

Look up 42239-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42239-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42239-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.